PMC:7170415 / 19153-20242
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
280 | 64-67 | Gene | denotes | IgG | |
281 | 72-82 | Species | denotes | SARS–CoV-2 | Tax:2697049 |
282 | 707-717 | Species | denotes | SARS–CoV-2 | Tax:2697049 |
283 | 718-729 | Species | denotes | coronavirus | Tax:11118 |
284 | 851-856 | Species | denotes | human | Tax:9606 |
285 | 857-870 | Species | denotes | coronaviruses | Tax:11118 |
286 | 939-947 | Species | denotes | patients | Tax:9606 |
287 | 333-349 | Disease | denotes | acute infections | MESH:D007239 |
288 | 493-502 | Disease | denotes | infection | MESH:D007239 |
289 | 589-609 | Disease | denotes | SARS–CoV-2 infection | MESH:C000657245 |
290 | 830-839 | Disease | denotes | infection | MESH:D007239 |
291 | 977-1006 | Disease | denotes | late complications of disease | MESH:D002493 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T26 | 50-53 | Body_part | denotes | IgA | http://purl.org/sig/ont/fma/fma62874 |
T27 | 55-58 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T28 | 64-67 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T29 | 116-121 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T30 | 125-131 | Body_part | denotes | saliva | http://purl.org/sig/ont/fma/fma59862 |
T31 | 471-479 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
T32 | 691-699 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T33 | 730-738 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T15 | 116-121 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T16 | 125-131 | Body_part | denotes | saliva | http://purl.obolibrary.org/obo/UBERON_0001836 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T80 | 72-76 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 339-349 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T82 | 493-502 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T83 | 589-593 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T84 | 600-609 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T85 | 707-711 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T86 | 830-839 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T182 | 10-15 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T183 | 116-121 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T184 | 116-121 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T185 | 213-218 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T186 | 664-669 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T187 | 747-748 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T188 | 851-856 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T189 | 1085-1087 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T23 | 730-738 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T18 | 409-423 | http://purl.obolibrary.org/obo/GO_0019076 | denotes | viral shedding |
T19 | 1053-1067 | http://purl.obolibrary.org/obo/GO_0019076 | denotes | viral shedding |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T136 | 0-294 | Sentence | denotes | Serologic tests that identify antibodies (such as IgA, IgM, and IgG) to SARS–CoV-2 from clinical specimens (such as blood or saliva), such as enzyme-linked immunosorbent assays, may be less complex than molecular tests and have the potential to be used for diagnosis in certain situations (46). |
T137 | 295-470 | Sentence | denotes | However, their utility for diagnosing acute infections is probably limited around the time of symptom onset, when viral shedding and transmission risk seem to be highest (32). |
T138 | 471-553 | Sentence | denotes | Antibody responses to infection take days to weeks to be reliably detectable (46). |
T139 | 554-670 | Sentence | denotes | Negative results would not exclude SARS–CoV-2 infection, particularly among those with recent exposure to the virus. |
T140 | 671-876 | Sentence | denotes | Cross-reactivity of antibody to non–SARS–CoV-2 coronavirus proteins is also a potential problem, whereby positive results may be the result of past or present infection with other human coronaviruses (47). |
T141 | 877-1089 | Sentence | denotes | Serologic assays might be more relevant in scenarios in which patients present to medical care with late complications of disease, when RT-PCR may be falsely negative, because viral shedding drops over time (48). |